Labeler
Breckenridge Pharmaceutical, Inc. NDC Codes
Breckenridge Pharmaceutical, Inc. lists 75 finished drug products in the FDA NDC Directory under NDC labeler code 51991.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Everolimus, Oxcarbazepine, Asenapine, Milnacipran Hydrochloride, Pomalidomide, Lacosamide, Duloxetine Delayed-Release, propranolol hydrochloride, Rivastigmine Transdermal System, Desvenlafaxine, Trimipramine, Tofacitinib, Zolpidem Tartrate, Tetracycline Hydrochloride, Eplerenone
- Active ingredients
- Everolimus, Oxcarbazepine, Asenapine maleate, Milnacipran hydrochloride, Pomalidomide, Lacosamide, Duloxetine hydrochloride, Propranolol hydrochloride, Rivastigmine, Desvenlafaxine succinate, Trimipramine maleate, Tofacitinib citrate
- NDC labeler codes
- 51991
- Strengths
- Everolimus 5 mg/1; Asenapine maleate 5 mg/1; Asenapine maleate 10 mg/1; Butalbital 50 mg/1; Caffeine 40 mg/1; Codeine phosphate 30 mg/1; Oxcarbazepine 150 mg/1; Oxcarbazepine 300 mg/1; Oxcarbazepine 600 mg/1; Tofacitinib citrate 5 mg/1; Tofacitinib citrate 10 mg/1; Zolpidem tartrate 6.25 mg/1; Zolpidem tartrate 12.5 mg/1; Milnacipran hydrochloride 12.5 mg/1; Milnacipran hydrochloride 50 mg/1; Milnacipran hydrochloride 100 mg/1; Milnacipran hydrochloride 25 mg/1; Pomalidomide 3 mg/1; Pomalidomide 4 mg/1; Pomalidomide 1 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Tablet, Extended release, Capsule, Delayed release pellets, Capsule, Extended release, Tablet, For suspension, Patch, Extended release, Injection, Solution, Injection, Solution, Concentrate, Injection
- Routes
- Oral, Sublingual, Intravenous, Transdermal, Intra-arterial, Intramuscular, Subcutaneous
- Drug classes (FDA established)
- Serotonin and Norepinephrine Reuptake Inhibitor, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Anti-epileptic Agent, Atypical Antipsychotic, Thalidomide Analog, beta-Adrenergic Blocker, Opioid Agonist, Aromatase Inhibitor, Cholinesterase Inhibitor, Tricyclic Antidepressant, Janus Kinase Inhibitor, gamma-Aminobutyric Acid A Receptor Positive Modulator, Tetracycline-class Antimicrobial, Aldosterone Antagonist, Anticholinergic, Estrogen, Progestin, Barbiturate, Central Nervous System Stimulant, Methylxanthine, Antirheumatic Agent, Catecholamine, Ergot Derivative, Allylamine Antifungal, Serotonin-3 Receptor Antagonist, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 149
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Desvenlafaxinedesvenlafaxine succinate | Desvenlafaxine succinate 100 mg/1 | Tablet, Extended releaseOral | 51991-312 | 51991-0312-0151991-0312-1051991-0312-11+4 more | — |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | InjectionIntravenous | 51991-144 | 51991-0144-17 | — |
| Duloxetine Delayed-Releaseduloxetine hydrochloride | Duloxetine hydrochloride 20 mg/1 | Capsule, Delayed release pelletsOral | 51991-746 | 51991-0746-0551991-0746-0651991-0746-90 | — |
| Duloxetine Delayed-Releaseduloxetine hydrochloride | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed release pelletsOral | 51991-747 | 51991-0747-1051991-0747-3351991-0747-90 | — |
| Duloxetine Delayed-Releaseduloxetine hydrochloride | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed release pelletsOral | 51991-748 | 51991-0748-1051991-0748-3351991-0748-90 | — |
| propranolol hydrochloride | Propranolol hydrochloride 60 mg/1 | Capsule, Extended releaseOral | 51991-817 | 51991-0817-0151991-0817-05 | — |
| propranolol hydrochloride | Propranolol hydrochloride 80 mg/1 | Capsule, Extended releaseOral | 51991-818 | 51991-0818-0151991-0818-05 | — |
| propranolol hydrochloride | Propranolol hydrochloride 120 mg/1 | Capsule, Extended releaseOral | 51991-819 | 51991-0819-0151991-0819-05 | — |
| propranolol hydrochloride | Propranolol hydrochloride 160 mg/1 | Capsule, Extended releaseOral | 51991-820 | 51991-0820-0151991-0820-05 | — |
| Methscopolamine Bromide | Methscopolamine bromide 2.5 mg/1 | TabletOral | 51991-191 | 51991-0191-01 | — |
| Methscopolamine Bromide | Methscopolamine bromide 5 mg/1 | TabletOral | 51991-192 | 51991-0192-0651991-0192-60 | — |
| Estradiol / Norethindrone Acetateestradiol and norethindrone acetate | Estradiol .5 mg/1; Norethindrone acetate .1 mg/1 | Tablet, Film coatedOral | 51991-623 | 51991-0623-28 | — |
| Letrozole | Letrozole 2.5 mg/1 | TabletOral | 51991-759 | 51991-0759-1051991-0759-3351991-0759-90 | — |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | 51991-526 | 51991-0526-01 | — |
| Anastrozole | Anastrozole 1 mg/1 | TabletOral | 51991-620 | 51991-0620-1051991-0620-3351991-0620-90 | — |
| Granisetron Hydrochloride | Granisetron hydrochloride 1 mg/1 | TabletOral | 51991-735 | 51991-0735-2051991-0735-32 | — |
| Ascomp with Codeinebutalbital, aspirin, caffeine and codeine phosphate | Butalbital 50 mg/1 + 3 more ingredients | CapsuleOral | 51991-074 | 51991-0074-0151991-0074-05 | — |
| Estradiol / Norethindrone Acetateestradiol and norethindrone acetate | Estradiol 1 mg/1; Norethindrone acetate .5 mg/1 | Tablet, Film coatedOral | 51991-474 | 51991-0474-28 | — |
| Oxcarbazepine | Oxcarbazepine 150 mg/1 | Tablet, Film coatedOral | 51991-053 | 51991-0053-0151991-0053-05 | — |
| Oxcarbazepine | Oxcarbazepine 300 mg/1 | Tablet, Film coatedOral | 51991-054 | 51991-0054-0151991-0054-05 | — |
| Oxcarbazepine | Oxcarbazepine 600 mg/1 | Tablet, Film coatedOral | 51991-055 | 51991-0055-0151991-0055-05 | — |
| Oxcarbazepine | Oxcarbazepine 150 mg/1 | Tablet, Film coatedOral | 51991-292 | 51991-0292-0151991-0292-05 | — |
| Oxcarbazepine | Oxcarbazepine 300 mg/1 | Tablet, Film coatedOral | 51991-293 | 51991-0293-0151991-0293-05 | — |
| Oxcarbazepine | Oxcarbazepine 600 mg/1 | Tablet, Film coatedOral | 51991-294 | 51991-0294-0151991-0294-05 | — |
| Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Butalbital 50 mg/1 + 3 more ingredients | CapsuleOral | 51991-073 | 51991-0073-01 | — |
Breckenridge Pharmaceutical, Inc.: common questions
- What is Breckenridge Pharmaceutical, Inc.'s NDC labeler code?
- 51991. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Breckenridge Pharmaceutical, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.